SYM FINANCIAL Corp lifted its stake in shares of Corteva (NYSE:CTVA) by 0.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 450,904 shares of the company’s stock after acquiring an additional 4,191 shares during the quarter. Corteva makes up approximately 8.4% of SYM FINANCIAL Corp’s holdings, making the stock its 5th biggest holding. SYM FINANCIAL Corp owned about 0.06% of Corteva worth $12,625,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of CTVA. Oakview Capital Management L.P. purchased a new position in Corteva during the second quarter valued at approximately $23,058,000. Legacy Advisors LLC purchased a new position in Corteva during the second quarter valued at approximately $210,000. Gateway Investment Advisers LLC purchased a new position in Corteva during the second quarter valued at approximately $15,124,000. Cullen Frost Bankers Inc. purchased a new position in Corteva during the second quarter valued at approximately $629,000. Finally, Bridge Creek Capital Management LLC purchased a new position in Corteva during the second quarter valued at approximately $5,559,000. 72.44% of the stock is currently owned by institutional investors and hedge funds.
In related news, EVP Timothy P. Glenn acquired 5,150 shares of the stock in a transaction dated Monday, November 4th. The stock was acquired at an average cost of $26.13 per share, for a total transaction of $134,569.50. Also, Director Klaus A. Engel acquired 18,393 shares of the stock in a transaction dated Friday, August 30th. The shares were bought at an average price of $30.00 per share, with a total value of $551,790.00. Following the completion of the purchase, the director now directly owns 25,253 shares of the company’s stock, valued at approximately $757,590. The disclosure for this purchase can be found here. Insiders have bought 29,368 shares of company stock valued at $838,567 over the last quarter.
NYSE CTVA traded up $0.05 on Friday, hitting $26.20. The stock had a trading volume of 2,999,502 shares, compared to its average volume of 5,615,176. The business has a fifty day moving average of $26.87. Corteva has a 52-week low of $24.35 and a 52-week high of $32.78.
Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, October 31st. The company reported ($0.39) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.46) by $0.07. The firm had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.97 billion. The firm’s quarterly revenue was down 1.8% compared to the same quarter last year. On average, analysts forecast that Corteva will post 1.24 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Friday, November 29th will be paid a dividend of $0.13 per share. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.52 annualized dividend and a dividend yield of 1.98%.
Several brokerages recently issued reports on CTVA. Zacks Investment Research raised shares of Corteva from a “sell” rating to a “hold” rating in a report on Friday, November 1st. SunTrust Banks cut their price objective on shares of Corteva from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Friday, October 11th. Monness Crespi & Hardt started coverage on shares of Corteva in a report on Wednesday, July 17th. They issued a “sell” rating and a $24.00 price target on the stock. Deutsche Bank lifted their price target on shares of Corteva from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, August 2nd. Finally, Barclays set a $32.00 price target on shares of Corteva and gave the stock a “hold” rating in a report on Friday, November 1st. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the stock. Corteva presently has a consensus rating of “Hold” and an average target price of $31.50.
Corteva Company Profile
Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.
Featured Article: What does RSI mean?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva (NYSE:CTVA).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.